Media
Media Contact
Financial & General Press
Henri von Haartman
Director of Investor Relations
+46 768 665 011
+358 29 370 0150
hvh@nanoform.com
Henri von Haartman
Director of Investor Relations
+46 768 665 011
+358 29 370 0150
hvh@nanoform.com
Pharmaceutical Press
Christian Jones
Chief Commercial Officer
+44 7804 474 771
+358 29 370 0150
christian.jones@nanoform.com
Christian Jones
Chief Commercial Officer
+44 7804 474 771
+358 29 370 0150
christian.jones@nanoform.com
Press releases
-
Regulatory January 22, 2021Nanoform’s Clinical Study Indicates Positive Interim Results
-
Non Regulatory January 11, 2021Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)
-
Regulatory January 4, 2021Nanoform sets a new near-term business target for 2021